UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma

Scientific reports, 2024-04, Vol.14 (1), p.8033-8033, Article 8033

2024

Volltextzugriff (PDF)

Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma

European journal of nuclear medicine and molecular imaging, 2018-05, Vol.45 (5), p.680-688

2018

Volltextzugriff (PDF)

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis

Leukemia, 2012-03, Vol.26 (3), p.559-562

2012

Volltextzugriff (PDF)

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis

Haematologica (Roma), 2015-07, Vol.100 (7), p.e280-e284

2015

Volltextzugriff (PDF)

Predictors of Quit Attempts and Abstinence Among Smokers not Currently Interested in Quitting

Nicotine & tobacco research, 2012-10, Vol.14 (10), p.1197-1204

2012

Volltextzugriff (PDF)

EZH2 alterations in follicular lymphoma: biological and clinical correlations

Blood cancer journal (New York), 2017-04, Vol.7 (4), p.e555-e555

2017

Volltextzugriff (PDF)

RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION

Hematological oncology, 2019-06, Vol.37 (S2), p.429-429

2019

Volltextzugriff (PDF)

Bulimic symptoms in undergraduate men and women: Contributions of mindfulness and thought suppression

Eating behaviors : an international journal, 2009-12, Vol.10 (4), p.228-231

2009

Volltextzugriff (PDF)

Evaluating the Effect of Access to Free Medication to Quit Smoking: A Clinical Trial Testing the Role of Motivation

Nicotine & tobacco research, 2014-07, Vol.16 (7), p.992-999

2014

Volltextzugriff (PDF)

Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial

Leukemia research, 2023-06, Vol.129, p.107058-107058, Article 107058

2023

Volltextzugriff (PDF)

Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis

Hematological oncology, 2023-06, Vol.41 (S2), p.346-347

2023

Volltextzugriff (PDF)

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas

Leukemia, 2007-03, Vol.21 (3), p.515-523

2007

Volltextzugriff (PDF)

CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.175-177

2023

Volltextzugriff (PDF)

COMBINING BASELINE TOTAL METABOLIC TUMOR VOLUME AND BETA‐2‐MICROGLOBULIN LEVELS PREDICTS OUTCOMES IN HIGH BURDEN FOLLICULAR LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.670-671

2023

Volltextzugriff (PDF)

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.147-148

2023

Volltextzugriff (PDF)

REALMA: Subset of patients with Marginal Zone Lymphomas from the French nationwide REALYSA real‐world prospective cohort

Hematological oncology, 2023-06, Vol.41 (S2), p.387-388

2023

Volltextzugriff (PDF)

IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY

Hematological oncology, 2023-06, Vol.41 (S2), p.223-225

2023

Volltextzugriff (PDF)

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.151-152

2023

Volltextzugriff (PDF)

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial

Annals of oncology, 2017-05, Vol.28 (5), p.1042-1049

2017

Volltextzugriff (PDF)

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia

Leukemia, 2016-03, Vol.30 (3), p.757-760

2016

Volltextzugriff (PDF)

The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma

Leukemia, 2011-04, Vol.25 (4), p.681-688

2011

Volltextzugriff (PDF)

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

Leukemia, 2013-01, Vol.27 (1), p.252-255

2013

Volltextzugriff (PDF)

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMAS: A LYSA STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.110-111

2023

Volltextzugriff (PDF)

GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma

Genes chromosomes & cancer, 2013-08, Vol.52 (8), p.764-774

2013

Volltextzugriff (PDF)

1 – 25 von 901

Suche als RSS-Feed

Aktive Filter

ThemaGeneral & Internal Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(703)
Mit Volltextzugriff
(598)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma

Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis

Predictors of Quit Attempts and Abstinence Among Smokers not Currently Interested in Quitting

EZH2 alterations in follicular lymphoma: biological and clinical correlations

RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION

Bulimic symptoms in undergraduate men and women: Contributions of mindfulness and thought suppression

Evaluating the Effect of Access to Free Medication to Quit Smoking: A Clinical Trial Testing the Role of Motivation

Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial

Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas

CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY

COMBINING BASELINE TOTAL METABOLIC TUMOR VOLUME AND BETA‐2‐MICROGLOBULIN LEVELS PREDICTS OUTCOMES IN HIGH BURDEN FOLLICULAR LYMPHOMA

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

REALMA: Subset of patients with Marginal Zone Lymphomas from the French nationwide REALYSA real‐world prospective cohort

IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia

The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMAS: A LYSA STUDY

GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma

Aktive Filter

Suchergebnisse filtern